Cargando…
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development
Patients with tuberous sclerosis complex (TSC) develop hamartomatous tumors showing loss of function of the tumor suppressor TSC1 (hamartin) or TSC2 (tuberin) and increased angiogenesis, fibrosis, and abundant mononuclear phagocytes. To identify soluble factors with potential roles in TSC tumorigene...
Autores principales: | Li, Shaowei, Takeuchi, Fumiko, Wang, Ji-an, Fuller, Christopher, Pacheco-Rodriguez, Gustavo, Moss, Joel, Darling, Thomas N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1378109/ https://www.ncbi.nlm.nih.gov/pubmed/16129702 http://dx.doi.org/10.1084/jem.20042469 |
Ejemplares similares
-
TSC1 and TSC2 Genotype in Tuberous Sclerosis Complex: Are Other Manifestations of this Multisystem Disease Affected by Genotype?
por: Darling, Thomas N., et al.
Publicado: (2021) -
Birt-Hogg-Dubé syndrome initially diagnosed as tuberous sclerosis complex
por: Pithadia, Deeti J., et al.
Publicado: (2019) -
Nipple angiofibromas with loss of TSC2 are associated with tuberous sclerosis complex
por: Nathan, Neera, et al.
Publicado: (2015) -
Phenotypic distinctions between mosaic forms of tuberous sclerosis complex
por: Treichel, Alison M, et al.
Publicado: (2019) -
Cutaneous Lesions as the Sole Presentation of Tuberous Sclerosis
por: Ahmed, Mohanad, et al.
Publicado: (2020)